Philippe Lopes-Fernandes
Corporate Officer/Principal at IPSEN
Network origin in Philippe Lopes-Fernandes first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
31
| Public Company | Pharmaceuticals: Major | 31 |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts.
13
| Private Company | Investment Managers | 13 |
Institut Supérieur de Gestion
12
| College/University | Other Consumer Services | 12 |
Histide AG
 Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland.
6
| Holding Company | Internet Software/Services | 6 |
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Philippe Lopes-Fernandes via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member President | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO | |
| BAXALTA INC | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| ESSEC Business School | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
ViTToria Biotherapeutics, Inc.
 ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Investor Relations Contact Director of Finance/CFO | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| Ipsen Biopharmaceuticals, Inc. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Private Equity Investor Founder | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Beech Tree SA
 Beech Tree SA Financial ConglomeratesFinance Beech Tree SA is an investment holding Luxembourger company. The private company is based in Luxemburg, Luxembourg. The company was founded in 2001. The CEO is Antoine Flochel. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| Massa Management SARL | Corporate Officer/Principal Corporate Officer/Principal | ||
| Beech Tree SARL | Director/Board Member Director/Board Member | ||
| G5 Santé | Chairman Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Baxter Ventures
 Baxter Ventures Investment ManagersFinance Baxter Ventures (Baxter Ventures) is a venture capital firm subsidiary of Baxter International, Inc. founded in 2011. The firm is headquartered in Deerfield, Illinois. | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GENFIT | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ACCOR ACQUISITION COMPANY S.A. | Financial Conglomerates | Director of Finance/CFO | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Investor Relations Contact | |
International Chamber of Commerce (France)
 International Chamber of Commerce (France) Miscellaneous Commercial ServicesCommercial Services International Chamber of Commerce (France) delivers solutions that address the major shifts taking place in the world economy. The non-profit company is based in Paris, France. and has subsidiaries in Cyprus, France and Hong Kong. ICC is the voice of world business championing the economy as a force for economic growth, job creation and prosperity. Making business work for everyone, everywhere, every day. The ICC arbitration rules are used all around the world to resolve disputes, administered by the ICC International Court of Arbitration®, the world’s premier arbitral institution. The rules assure parties of a neutral framework for the resolution of cross-border disputes. The CEO of the French company is Lew W. Cramer. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Cercle Montesquieu SCI | President | ||
Floem SAS
 Floem SAS Miscellaneous Commercial ServicesCommercial Services Floem SAS provides business and management consulting services. The private company is based in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Chairman | |
| Association Française Des Femmes Juristes | Corporate Officer/Principal | ||
| Franco-British Lawyers Society | Director/Board Member | ||
| Montesquieu Circle | Corporate Officer/Principal | ||
| Drexel University | College/University | Doctorate Degree | |
| EIFFAGE S.A. | Engineering & Construction | Director/Board Member | |
| France Competition Council | General Government | Corporate Officer/Principal |
Statistics
International
| United States | 26 |
| France | 16 |
| Luxembourg | 5 |
| United Kingdom | 5 |
| Netherlands | 2 |
Sectoral
| Health Technology | 24 |
| Finance | 7 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 313 |
| Corporate Officer/Principal | 121 |
| Chairman | 52 |
| Independent Dir/Board Member | 50 |
| Chief Executive Officer | 47 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Michèle Ollier | 33 |
| Geeta S. Vemuri | 33 |
| Marc M. P. de Garidel | 31 |
| Norbert Riedel | 29 |
| Nicole Vitullo | 28 |
| Bruce Peacock | 28 |
| Antoine Flochel | 24 |
| Jak Knowles | 24 |
| Bjarni K. Thorvardarson | 17 |
| Karen Witts | 17 |
| Carol Xueref | 17 |
| Howard Mayer | 16 |
| Robert Parkinson | 16 |
| Guillaume Hemmerlé | 16 |
- Stock Market
- Insiders
- Philippe Lopes-Fernandes
- Company connections
